In addition, increased levels of adiponectin have been reported in CSF from patients diagnosed with multiple sclerosis (Hietaharju et al., 2010) or Alzheimer's disease (Une et al., 2011), and APOE is associated with a genetic predisposition to late-onset Alzheimer's disease (Burke and Roses, 1991-1992). The gene discussed is ADIPOQ; the disease is early-onset autosomal dominant Alzheimer disease.